Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The herpes simplex virus (HSV) entry process is a complex, multi-step mechanism involving coordinated interactions between viral glycoproteins and specific host cell surface receptors. This process enables the virus to attach, penetrate, and deliver its genetic material into the host cell for replication. Key steps include attachment, receptor engagement, membrane fusion or endocytosis, capsid transport, and genome release. Viral glycoproteins gB, gC, gD, and gH/gL, along with host cell receptors like heparan sulfate proteoglycans, Nectin-1/-2, and HVEM, are crucial for this process. The virus exploits calcium signaling pathways and microtubule-based transport. Entry variations exist depending on target cell type. After nuclear delivery of DNA, subsequent steps include genome replication and assembly within infected cells before new virions are released.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Herpes Simplex Virus Entry Process (HSV Entry Process).